🔎 Trials Near Me

Home › Autoimmune Diseases › Pennsylvania › Philadelphia

Autoimmune Diseases clinical trials in Philadelphia, PA

16 studies for Autoimmune Diseases are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Autoimmunity After Checkpoint Blockade

RecruitingObservational study
  • University of Pennsylvania - Abramson Cancer Center, Philadelphia
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT04119713

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

RecruitingPhase 3
  • Perelman Center for Advanced Medicine (PCAM) Hospital of The University of Pennsylvania Penn Blood Disorders Program, Philadelphia
  • Lewis Katz School of Medicine at Temple University, Philadelphia
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

RecruitingPhase 2/3
  • Children's Hospital of Philadelphia - Accepting Young Adult and Juvenile Patients, Philadelphia
Ages 6 to 75 · All sexes · Updated Sep 17, 2026 · NCT06154252

A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis

RecruitingPhase 2
  • Fox Chase Cancer Center- Temple BMT, Philadelphia
Ages 16 to 70 · All sexes · Updated Sep 17, 2026 · NCT07328581

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

RecruitingPhase 3
  • Perelman Center for Advanced Medicine (PCAM) Hospital of The University of Pennsylvania Penn Blood Disorders Program, Philadelphia
  • Lewis Katz School of Medicine at Temple University, Philadelphia
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06948318

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

RecruitingPhase 3
  • GSK Investigational Site, Philadelphia
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06572384

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

RecruitingPhase 1/2
  • Children's Hospital of Philadelphia, Philadelphia
Ages 18 to 65 · All sexes · Updated Aug 26, 2026 · NCT06121297

Abatacept for the Treatment of Giant Cell Arteritis

RecruitingPhase 3
  • University of Pennsylvania, Philadelphia
Ages 50 and older · All sexes · Updated Aug 20, 2026 · NCT04474847

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

RecruitingPhase 3
  • The Children's Hospital of Philadelphia, Philadelphia
Ages 12 and older · All sexes · Updated Aug 6, 2026 · NCT06056297

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

RecruitingPhase 2/3
  • Thomas Jefferson University Hospital, Philadelphia
Ages 18 to 75 · All sexes · Updated Jul 29, 2026 · NCT06193889

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RecruitingObservational study
  • Children's Hospital of Philadelphia, Philadelphia
  • Nemours - Alfred I. duPont Hospital for Children, Brandywine · 21 mi away
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

RecruitingPhase 1
  • Jefferson Einstein Hospital Philadelphia, Philadelphia
Ages 12 to 70 · All sexes · Updated May 22, 2026 · NCT06308978

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

RecruitingPhase 1
  • Temple University Hospital, Philadelphia
Ages 18 and older · All sexes · Updated Feb 25, 2026 · NCT06626919

Central Vein Sign in Multiple Sclerosis Extension Study

Recruiting
  • University of Pennsylvania, Philadelphia
Ages 18 to 65 · All sexes · Updated Feb 20, 2026 · NCT07424027

X-linked Moesin Associated Immunodeficiency

RecruitingObservational study
  • Perelman School of medecine, Philadelphia
Ages 4 to 80 · Men · Updated Apr 25, 2025 · NCT06278337

About Autoimmune Diseases

Autoimmune diseases are where your immune system attacks healthy cells in your body by mistake. Learn about the symptoms, tests, and treatments.

More about Autoimmune Diseases on MedlinePlus

Autoimmune Diseases trials in other cities

Other studies in Philadelphia

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.